X-37

X-37 is a drug development company that utilizes advanced artificial intelligence technology from Atomwise, Inc. to discover new drug candidates by screening vast compound libraries against high-value drug targets. The X-37 team possesses extensive expertise in selecting high-value drug targets and drug development. X-37 has initiated five development projects in areas of high medical need, including cancer, autoimmune diseases, and coagulation disorders.